Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Medical Innovation

SSTI Recognizes Outstanding Initiatives Driving Regional Prosperity, Innovation; NJ Innovation Institute Among 2017 Honorees

Washington, DC, September 22, 2017 — From teaching high school students in rural western Kentucky how to become entrepreneurs to connecting entrepreneurs with a worldwide network of partners in a virtual hub, organizations are finding innovative ways to build regional prosperity.

Four outstanding examples — including New Jersey Innovation Institute’s Health IT Connections program — were recognized September 14 by the State Science & Technology Institute (SSTI), a national organization working to strengthen initiatives to create a better future through science, technology, innovation and entrepreneurship. Continue reading

Rutgers Research: A Fat-Regulating Enzyme Could Hold the Key to Obesity, Diabetes, Cancer, Other Diseases

Dr. George Carman

New Brunswick, NJ, September 21, 2017 — Todd B. Bates reports for Rutgers Today that It had already been known that the enzyme known as phosphatidic acid phosphatase plays a crucial role in regulating the amount of fat in the human body.  Controlling it is therefore of interest in the fight against obesity.

But scientists at Rutgers University-New Brunswick have now found that getting rid of the enzyme entirely can increase the risk of cancer, inflammation and other ills. Their findings were published online in the Journal of Biological Chemistry last month.

“The goal of our lab is to understand how we can tweak and control this enzyme,” said George M. Carman, Ph.D., Board of Governors professor in the Department of Food Science in the School of Environmental and Biological Sciences. Continue reading

Rutgers NJ Medical School Research: Memory Decline After Head Injury May be Prevented by Slowing Brain Cell Growth

New Brunswick, NJ, September 20, 2017 — Robin Lally reports on Rutgers Today that the excessive burst of new brain cells after a traumatic head injury that scientists have traditionally believed helped in recovery could instead lead to epileptic seizures and long-term cognitive decline, according to a new Rutgers New Jersey Medical School study.

In the September issue of Stem Cell Reports, Viji Santhakumar, Ph.D., associate professor in Department of Pharmacology, Physiology and Neuroscience, and her colleagues, challenge the prevailing assumption by scientists in the field that excessive neurogenesis (the birth of new brain cells) after injury is advantageous. Continue reading

BIO Report Finds Bioscience Drives Economic Growth in States Across U.S.

Washington, DC, September 20, 2017 — A report from Biotechnology Innovation Organization (BIO) unveiled in June concludes that the bioscience industry has had a positive impact on states’ economies and continues to be a driver of economic growth.

According to the new BIO report released in June, state lawmakers have recognized the importance of the industry, the authors state, and have responded to challenges facing the bioscience companies with legislative efforts focused on a supportive business climate. Continue reading

Hundreds of Thousands Rallied, But Where Does the March for Science Go Now?

Washington, DC, September 19, 2017 — Lev Facher reports on STAT that the hundreds of thousands of people who rallied on the National Mall and in cities worldwide for the March for Science in April came to be noticed.

It was a march meant to demonstrate enthusiasm and political clout, and by those measures, organizers believe they succeeded.

But as two dozen of them met in New York the following month for a debrief, they faced an obvious reality: A grass-roots organization that was quickly formed to plan a singular event was not, at least immediately, equipped for far-reaching and long-term science advocacy. Continue reading

Rutgers Research: Cloning Thousands of Genes for Massive Protein Libraries

New Brunswick, NJ, September 18, 2017 — Discovering the function of a gene requires cloning a DNA sequence and expressing it.  Until now, this was performed on a one-gene-at-a-time basis, causing a bottleneck.

Scientists at Rutgers University-New Brunswick in collaboration with Johns Hopkins University and Harvard Medical School have invented a technology to clone thousands of genes simultaneously and create massive libraries of proteins from DNA samples, potentially ushering in a new era of functional genomics. Continue reading

Event: HINJ and Rutgers Biomedical Engineering Medical Device Development Center Kick Off Forum Series with ‘Innovations in 3-D Printing’ on September 19

Piscataway, NJ, September 18, 2017 — Please join the Rutgers Biomedical Engineering Medical Device Development Center and the HealthCare Institute of New Jersey (HINJ) for “Innovations in 3-D Printing: The Latest Technology in Industry” on Tuesday, September 19 at Rutgers’ Busch Campus in Piscataway, NJ.

The free event will be the first in Rutgers and HINJ’s Fall series of educational panels and seminars that focus on the medical device industry.

Attendees will learn the latest about 3-D printing technology and its innovative uses in pre-surgical planning, training and medical device industry applications. Continue reading

PhRMA Releases ‘Research in Your Backyard’ for New Jersey; PhRMA, HINJ and WWFH-NJ Host Discussion Focused on Biopharma Research in Garden State

New Brunswick, NJ, September 16, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) on June 28 released a new report entitled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in New Jersey,” which finds that 25,127 patients participated in clinical trials around the state in 2013, generating an estimated economic impact of $617 million.

The report was released at an event co-hosted by PhRMA, the HealthCare Institute of New Jersey (HINJ) and We Work for Health New Jersey (WWFH-NJ) that was held at the Rutgers Cancer Institute of New Jersey on June 28.

In addition to a presentation of the new PhRMA report, the event featured a panel discussion of industry experts that was moderated by HINJ President and Chief Executive Officer Dean J. Paranicas.  The panelists were: Continue reading

PhRMA’s ‘Research in Your Backyard’ for New Jersey Explores Clinical Trials’ State Impact

New Brunswick, NJ, September 15, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) on June 28 released a new report entitled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in New Jersey,” which finds that 25,127 patients participated in clinical trials around the state in 2013, generating an economic impact of $617 million.

The report was released at an event co-hosted by PhRMA, the HealthCare Institute of New Jersey (HINJ) and We Work for Health New Jersey (WWFH-NJ) that was held at the Rutgers Cancer Institute of New Jersey. Continue reading

3-D Printing Advances Make the Technology More Useful for Surgery, Implants, Creating Drugs

New York, NY, September 15, 2017 — Aili McConnon reports in The Wall Street Journal that Mayo Clinic is part of a web of organizations racing to find ways to use 3-D printing to improve health care.

Some research institutions, including the Mayo Clinic, have set up on-site printing labs in partnership with such makers of 3-D printers as Stratasys, 3D Systems and Formlabs.

McConnon reports that General Electric Co. and Johnson & Johnson are diving in, too, with GE focused on 3-D printers and translating images from various sources into 3-D objects, and J&J focused on developing a range of materials that can be used as “ink” to print customized objects. Continue reading